Concord Healthcare, a subsidiary of Concord Medical Services Holdings Limited, has made significant advancements in tumor diagnosis and treatment with the official release of its Proton Therapy Large Model. This large language model, the first of its kind in China, is specifically designed for proton therapy and has been successfully deployed at the Guangzhou Concord Cancer Hospital. The model leverages over 10,000 high-quality radiotherapy cases and integrates data from Proton China and professional journals to enhance its training. Since its implementation, the proton therapy at Guangzhou Concord Cancer Hospital has demonstrated precise treatment capabilities, significant efficacy, and reduced side effects in patient care. Concord Healthcare's efforts mark a notable progression in the field of precise tumor treatment.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.